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Metagenomic analysis of microbe-mediated
vitamin metabolism in the human gut
microbiome
Promi Das1, Parizad Babaei1 and Jens Nielsen1,2*
Abstract
Background: Human gut microbial communities have been known to produce vitamins, which are subsequently
absorbed by the host in the large intestine. However, the relationship between species with vitamin pathway
associated functional features or their gene abundance in different states of health and disease is lacking. Here, we
analyzed shotgun fecal metagenomes of individuals from four different countries for genes that are involved in
vitamin biosynthetic pathways and transport mechanisms and corresponding species’ abundance.
Results: We found that the prevalence of these genes were found to be distributed across the dominant phyla of
gut species. The number of positive correlations were high between species harboring genes related to vitamin
biosynthetic pathways and transporter mechanisms than that with either alone. Although, the range of total gene
abundances remained constant across healthy populations at the global level, species composition and their
presence for metabolic pathway related genes determine the abundance and functional genetic content of vitamin
metabolism. Based on metatranscriptomics data, the equation between abundance of vitamin-biosynthetic
enzymes and vitamin-dependent enzymes suggests that the production and utilization potential of these enzymes
seems way more complex usage allocations than just mere direct linear associations.
Conclusions: Our findings provide a rationale to examine and disentangle the interrelationship between B-vitamin
dosage (dietary or microbe-mediated) on gut microbial members and the host, in the gut microbiota of individuals
with under- or overnutrition.
Keywords: B-vitamins, Gut metabolism, Metagenomics, Metatranscriptomics, Vitamin prototrophs, Vitamin
consumers
Background
Human gut commensals have been known to be signifi-
cant producers of vitamins, which in turn serve as an
essential coenzymes for a broad class of metabolic reac-
tions. Thus, gut commensals can synthesize vitamin K2
as well as the water-soluble B-vitamins, such as biotin,
cobalamin, folic acid, niacin, pantothenic acid, pyridox-
ine, riboflavin and thiamine [1–4]. Microbial species that
can synthesize vitamins de novo are known as vitamin
prototrophs, and species that lack biosynthetic pathways
and rely on exogenous sources are known as vitamin
auxotrophs. Dietary vitamins are absorbed in the small
intestine, whereas most of the microbe-mediated vitamin
production takes place in the large intestine and hereby
produced vitamins can eventually be absorbed by the
host via specialized carrier-mediated systems, except for
cobalamin [2, 5]. As the process of vitamin absorption
has evolved to take place at different spatial sites, it
would be reasonable to expect that there is no competi-
tion for dietary vitamins between vitamin consumers
and vitamin uptake transporters in the colon and the
small intestine, respectively.
Systematic assessment of the vitamin biosynthetic cap-
abilities in gut bacteria based on genomic analysis has
revealed three significant features: (a) varying prevalence
and distribution of biosynthetic and transporter genes in
the genomes of gut commensals; (b) lack of a complete
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pathways in the genome for some species; and (c) pairs
of species with complementary patterns of presence and
absence of genes encoding enzymes for biosynthesis of a
specific vitamin [6, 7]. Furthermore, gut microbial con-
tribution to vitamin metabolism has been recognized
from several mice studies between conventional and
germ-free mice experiments [8–11] and whole-genome
metagenomic studies [12]. Most of the studies related to
gut bacterial mediated B-vitamin metabolism have inves-
tigated the overall biosynthetic capacity of these vitamins
between different groups [13, 14]. However, no study so
far has reported details on the relationship between vita-
min prototrophs and their consumers; abundance of
vitamin biosynthetic gene(s) and uptake transporter(s)
using human fecal metagenomic data; and expression
level of vitamin biosynthetic genes and
vitamin-dependent enzymes from human fecal meta-
transcriptomics data.
Therefore, to gain insights into microbe-mediated vita-
min metabolism from the human fecal metagenomics
and metatranscriptomics datasets, research hypotheses
were formulated as follows: (i) Assuming fecal metage-
nomics as a representative proxy for gut microbiota, are
the abundances of different vitamin metabolic genes
associated to the country or health status of an individ-
ual?; (ii) Assuming vitamin metabolism as an integral
part of central carbon metabolism, how is the prevalence
of these metabolic genes distributed across the diverse
phylum?; (iii) Based on the classification of microbial
species, as vitamin producers or consumers or both,
what type of species pair are correlated predominantly?;
(iv) Based on the available functional annotation of these
genes, is it the microbial diversity or the abundance of
microbial members contributing to the variation in
case-control groups? and (v) Are there parallel depend-
encies between the expression level of vitamin biosyn-
thetic enzymes and vitamin-dependent enzymes?.
Results
Our analysis involved several steps: (a) Quantitative
analysis of the vitamin biosynthetic and transporter
related genes between different groups; (b) Charting the
information of the identified genes at their corresponding
species and phyla level; (c) Identification of co-occurrence
patterns between vitamin producers and consumers, and
using this information to gain insights into the possible
metabolic correlations based on species abundance; (d)
Metabolic reconstructions of genome-scale metabolic
models were deployed to visualize the community-level
metabolic potential of abundant gut species in diverse
cohorts, and (e) Quantifying the abundance of vitamin
biosynthetic enzymes and vitamin-dependent enzymes in
an IBD (Inflammatory Bowel Disease) cohort in compari-
son to healthy controls.
Metagenomic abundance of vitamin biosynthetic
pathways and transporters in healthy individuals from
different countries
To evaluate if the abundances of microbial-mediated
vitamin metabolic genes are dependent on the country
of origin or not, linear and logistic regression analyses,
without controlling for other confounding factors, was
carried out. The result suggested an association between
vitamin metabolic gene abundances with healthy samples
originating from China (F-statistic, p < 0.01, as a country
variable). However, the gene abundances from healthy
samples of other countries, i.e., Denmark, Spain, and USA
showed no significant association to the corresponding
country variable. Extraction of DNA was performed in the
Beijing Genome Institute (BGI) for the samples from
China, Denmark, and Spain. Although none of these stud-
ies provided diet information for the samples, it would be
reasonable to speculate that the observed differences
could be a diet-dependent effect (based on Western and
non-Western diets).
Henceforth, we compared the normalized abundances
of eight B-vitamin and menaquinone related biosynthetic
and transporter genes in the healthy subjects from these
different populations. On comparison of healthy samples
among four different countries, we found that individ-
uals from China had significantly higher gene abundance
(Mann–Whitney test, p < 0.01) for each vitamin type,
than that from USA, Spain, and Denmark (Fig. 1 and
Additional file 1: Table S1). For each vitamin, the nor-
malized abundance of the biosynthetic genes ranged
around similar range as shown in Fig. 1 for all the
healthy individuals irrespective of their origin of country.
Additionally, genes involved in the biosynthetic path-
ways were found to be significantly higher than their
corresponding transport related pathways (Mann–Whit-
ney test, p < 0.01). However, it is of caution that as the
bacterial vitamin transporters could belong to a diverse class
of protein families [15, 16] due to their evolutionary variabil-
ity, functional annotation of these transporters through
bioinformatic approach remains challenging [17, 18].
Metagenomic abundance of vitamin biosynthetic
pathways and transporters in different states of health
Many functional features of gut microbiota have been
shown to correlate with health and disease, and we
therefore evaluated if vitamin metabolism by gut com-
mensals is associated with the host health status. To do
so, we performed similar analysis as described above
between country-matched healthy controls and diseased
subjects. The comparison for gene abundances included
the following groups: healthy controls and the newly-on-
set IBD (inflammatory bowel disease) subjects from USA
[14]; healthy controls and T2D (type 2 diabetes) subjects
from China [13]; and healthy controls and IBD subjects
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under clinical remission from Spain [19]. The results sug-
gested that gene abundances from T2D subjects in China
(as a diagnosed variable) showed an association for vita-
min metabolism (F-statistic, p < 0.01), while the gene
abundances from IBD subjects from USA and Spain
showed no significant association with disease status.
Comparing the gene abundances between the country-
matched groups, we found that the T2D subjects from the
Chinese cohort showed substantial and significant differ-
ence for all the vitamin types associated with biosynthetic
enzymes and transporters (except for biotin and riboflavin)
in comparison with the country-matched healthy controls
(Mann–Whitney test, p < 0.01) (Fig. 2). On the other hand,
IBD subjects (both onset and clinical remission ones) were
not found to be significantly different concerning vitamin
metabolism when compared to their respective country-
matched healthy controls. To validate our analytical
method, we tested and found that our findings were
consistent with what has been reported earlier [20]. Hence-
forward, data for healthy subjects were used to get insight
into how these genes map to bacteria from different phyla.
Phylogenetic origin of vitamin pathway genes
To compare the taxonomic profile of vitamin metabolic
genes (biosynthesis and transporter genes) at phylum or
species level, each of the mapped gene identifiers were
used to retrieve the lineage information from UniProt
database. In Fig. 3, we show how vitamin metabolic
genes are prevalent across different phyla, which might
suggest vitamin metabolism being as a part of core func-
tion in gut microbial metabolic modules. Additional file
2: Figure S1 shows a network of associations between
species with mapped vitamin-related gene and its corre-
sponding phylum. This figure reveals that the vitamin
related pathways are mostly found in the phylum Firmi-
cutes with about 49%, followed by Proteobacteria with
about 19%, Bacteroidetes with about 14% and Actino-
bacteria with about 13%. Additional file 3: Figure S2
shows a network of associations between vitamin biosyn-
thetic capabilities and phylum with species information.
For every vitamin type, the number of species having
prevalence of a biosynthetic pathway seemed to be higher
than that of species with transporter mechanisms. Among
Fig. 1 Violin plot showing total normalized abundance of genes in healthy fecal samples from four different countries (i.e. USA, China, Denmark,
Spain). Microbial genes annotated to KOs were grouped into the respective type of B and K2 vitamins. The pointrange refers to the mean and
standard deviation. The shape represents the kernel probability density of the data across different vitamin types are abbreviated as: biotin (BIO),
cobalamin (COB), folate (FOL), menaquinone (MEN), niacin (NIA), pantothenate (PAN), pyridoxine (PYR), riboflavin (RIB), thiamine (THI). Suffixes that
end with -B and -T are related to biosynthetic and transporter related genes respectively. [For detailed statistical results, the reader is referred to
the Additional file 1: Table S11, where the asterisks indicate ns: p > 0.05, *: p < = 0.05, **: p < = 0.01, ***: p < = 0.001, ****: p < = 0.0001 (Mann-
Whitney Wilcoxon test)]
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the various vitamin transporters, species encoding
thiamine transporter dominated in contrast to folate
transporter being the lowest in number. However, from
Additional file 3: Figure S2, it also becomes apparent that
there are three types of species that differ with respect to
functional characteristics related to vitamin metabolism,
i.e. vitamin genes related to biosynthesis or transporters or
both. Based on this, we categorized 171 microbial species
as Producer (P), Consumer (C) and Producer-Consumer
(Dual) for three specific vitamins (biotin, cobalamin, and
thiamine) in the following analysis.
Network association between vitamin prototrophs and
vitamin consumers
Given a hypothetical situation where there is a direct
dependence between public-good-producing bacteria
and its consumer, it is expected to observe a stronger
association of their coexistence at the level of species
abundance. Based on the presence or absence of genes
encoding proteins required in vitamin biosynthetic path-
ways or transporter mechanisms or both, each microbial
species was assigned as either vitamin prototrophs
(producers) or vitamin consumers (consumers) or
producer-consumer (dual) respectively for every vitamin
type. Therefore, to estimate interactions between vitamin
prototrophs and consumers, we performed a correlational
analysis between species with all possible phenotypes. Of
total 7021 possible pairs of species combinations (171
species (675 strains) considered), 2030 (i.e. 28.9%) and 590
(i.e. 8%) were significantly positive and negative correlated,
respectively (Mann–Whitney test, p < 0.01). Among the
positive correlations, with a correlation coefficient greater
than 0.7, we observed that a pair of species originating
from the same phylum could coexist, probably due to
their evolutionary similarities. However, we also observed
a similar level of coexistence for a pair of species originat-
ing from different phyla. For example, species from two
different phyla, Lactobacillus acidophilus (Firmicutes) and
Citrobacter koseri (Proteobacteria) had a high and positive
correlation coefficient r = 0.81.
Based on the high prevalence of species with vitamin
metabolic pathways among different phyla as derived
from Fig. 3, we focused our next correlational analysis
(using similar approached as described above) to the
Fig. 2 Violin plot showing total normalized abundance of genes in fecal samples from four different countries (i.e. USA, China, Denmark, Spain)
under different states of health and disease. Microbial genes annotated to KOs were grouped into the respective type of B and K2 vitamins. The
pointrange refers to the mean and standard deviation. The shape represents the kernel probability density of the data across different vitamin
types are abbreviated as: biotin (BIO), cobalamin (COB), folate (FOL), menaquinone (MEN), niacin (NIA), pantothenate (PAN), pyridoxine (PYR),
riboflavin (RIB), thiamine (THI). Suffixes that end with -B and -T are related to biosynthetic and transporter related genes respectively. The asterisks
on the top indicate ns: p > 0.05, *: p < = 0.05, **: p < = 0.01, ***: p < = 0.001, ****: p < = 0.0001 (Mann-Whitney Wilcoxon test)
Das et al. BMC Genomics          (2019) 20:208 Page 4 of 11
most prevalent three B-vitamins among microbial spe-
cies, i.e. biotin, cobalamin, and thiamine involving both
biosynthetic and transporter related genes respectively
to estimate interactions between these specific vitamin
prototrophs and consumers. Contrary to our hypothesis,
we found that species with dual functional traits (i.e.
containing genes for both biosynthesis and transport of
the same vitamin) contributed to a notable fraction of
positive correlations among the possible phenotypes
(Additional file 4: Figure S3). On the other hand, the
co-occurrence of species with single phenotype (i.e., ei-
ther producer/P or consumer/C) and dual phenotypes
belonged to both positive and negative correlations.
These observations hint that the species with dual
phenotypes could drive stronger relationships than the
ones with either limited or less functional traits. It is
well-known, that communities of species with multiple
functional features respond well to changes in the
Fig. 3 Circular plot with links representing the prevalence of vitamin metabolism among different phyla of human gut microbiota. Each phylum
is colored and each type of vitamin phenotype is shown in grey. The vitamin types are abbreviated as: biotin (BIO), cobalamin (COB), folate (FOL),
menaquinone (MEN), niacin (NIA), pantothenate (PAN), pyridoxine (PYR), riboflavin (RIB), thiamine (THI). Suffixes that end with -B and -T are related
to biosynthetic and transporter related genes respectively
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environment, thereby influencing the net outcome of a
community assembly [21–23]
Genome annotation coverage of biosynthetic pathways
Next, we sought to visualize the presence and absence of
vitamin pathway related reactions in each cohort to gain
insights into how conserved each pathway is, across
different populations. As depicted in Additional file 5:
Figure S4, riboflavin seems to be well represented and
conserved among all species across all the four cohorts
regardless of the health status. This conservation could
also be due to the limited number of reactions involved
in riboflavin pathway compared to other pathways.
Contrarily, menaquinone or vitamin K2, has the least
number of species with its biosynthesis pathway present.
Perhaps, human microbiome might have evolved to have
a reduced dependence of menaquinone production from
the gut microbiota as proposed earlier [24]. In case of
folate, the majority of the reactions involved in its biosyn-
thesis were observed to be present except for four reactions
which concerned interconversions of tetrahydrofolate,
dihydrofolate, and folate using NADH or NADPH as cofac-
tors and one ATP-forming reaction carried out by folylpoly-
glutamate synthase enzyme. Biotin and thiamine appeared
to be vitamins with a major part of their biosynthetic
reactions with their annotations missing. These are related
to fatty acid metabolism and the upstream part of the
biotin synthesis pathway provides a long-chain acyl as
the starting point for the biosynthesis. In case of
thiamine, three phosphatase reactions involving inter-
conversion of thiamine monophosphate, −diphosphate,
−triphosphate and thiamine were absent. For the rest
of the vitamins, the incompleteness of their biosyn-
thesis pathway was observed for many species, which
is in line with previous studies as it has been sug-
gested that vitamin biosynthesis could be carried out
as complementary tasks between several bacteria, each
harboring a part of the pathway [25].
Furthermore, for the American and Chinese cohort,
we investigated the presence and absence of reactions in
the biosynthesis pathway of each vitamin considering
the abundance of bacterial species. As depicted in Fig. 4a,
it is noticeable that species with biosynthetic reactions
of riboflavin, pantothenate, and pyridoxine have rela-
tively higher coverage when compared to the other
vitamin types. It is also to be noted that species from
genera Bacteroides, namely B. uniformis, B. stercoris, B.
vulgatus, B. fragilis, and B. caccae are among the most
abundant species with relatively high coverage of biosyn-
thetic capabilities for all vitamins. Although the overall
coverage of vitamin biosynthetic pathways is rather high,
the same trend is not observable in case of biotin,
A B
Fig. 4 Heatmap showing relative gene abundance of reactions associated with gene annotations of vitamin biosynthetic pathways in genome-
scale metabolic models (GEMs) based on species abundance of abundant gut bacteria (a) American cohort and (b) Chinese cohort. The x-axis
represents the reaction IDs associated to each vitamin pathway and on the y-axis the list of abundant gut bacteria are shown. Light blue and
dark blue (on the left) represents healthy and diseased of associated reaction abundance to each microbial species (on the right) respectively.
Grey color in every row represents absence of species in the cohort and the purple color key (dark to light color) represents abundance from
high to low values
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cobalamin, and niacin which have incomplete pathways
in many cases.
For the Chinese cohort (Fig. 4b), we noticed that the
abundant species profile differs from that of the American
cohort, possibly reflecting a population-specific (which is
mostly due to country variation) gut microbiota. It is again
evident from this that Bacteroides species have most of
the vitamin biosynthesis pathways covered except for
cobalamin due to differences at the species level. Besides,
in the Chinese population, there are many species from
Firmicutes amongst the abundant ones, which suggest
that based on the Bacteroidetes/Firmicutes ratio there
may be a change in abundance of vitamin related genes.
Expression level of vitamin biosynthetic enzymes and
vitamin-dependent enzymes in an IBD cohort
Based on the availability of metatranscriptomics dataset
from the American cohort analyzed above, we sought to
investigate the mRNA sequences of microbe-mediated
vitamin related enzyme as computed by HUMAnN2
[26]. Functional profiling of mRNA normalized features
(i.e., vitamin biosynthesis) in this cohort reveals that
there is a low abundance of cobalamin and thiamine bio-
synthesis related enzymatic genes expressed in the IBD
samples compared to healthy controls (Mann–Whitney
test, p < 0.01) (Fig. 5a). These findings were consistent
with a similar pattern observed in a previous study
where B-vitamins were measured to be lower in plasma
samples of IBD subjects [27–29].
However, the expression level of biotin biosynthetic
enzymes was found to be significantly higher in the IBD
subjects compared to healthy controls (Mann–Whitney
test, p < 0.01). To examine this, we inspected whether
the abundance of biotin synthesizers were significantly
abundant or not in the IBD subjects than that of the
healthy controls (especially, for the coordinated set of
samples where the metagenomics and metatranscrip-
tomics were carried out). Interestingly, we found that
species with only biosynthetic pathways for biotin were
significantly more abundant in the IBD subjects whereas
species with biotin transporters were significantly less
abundant in the IBD subjects compared to healthy
controls (Additional file 6: Figure S5).
These observations once again highlight the signifi-
cance of the microbial contribution to human health
status. Furthermore, we analyzed the expression level of
these vitamin-dependent enzymes to discern the connec-
tion between their synthesis and usage. We found that
the abundance of biotin-dependent enzymes had an in-
reverse pattern to that of their biosynthesis level,
whereas, thiamine utilization potential as well as its bio-
synthetic potential were less abundant in IBD subjects
when compared to the healthy controls (Fig. 5b)
(Mann–Whitney test, p < 0.01). Variation in vitamin
synthesis and utilization level among these three vita-
mins is likely to reflect the complexity of the gut micro-
biota towards resource allocation and reuse of enzymes.
Discussion
Here we used whole-genome metagenomic sequences
and performed bioinformatic analyses to gain an under-
standing of the microbe-mediated vitamin biosynthetic
pathways and transport mechanism of the human gut
microbiota. Fecal metagenomes sampled from four
different countries were analyzed together to improve
the robustness of our predictions at a statistical level.
A B
Fig. 5 Violin plot showing mean relative abundance of (a) vitamin-biosynthetic genes and (b) vitamin-dependent genes in fecal samples from
American cohort. Microbial genes annotated to EC numbers were grouped into the respective type of B and K2 vitamins. The pointrange refers to
the mean and standard deviation. The shape represents the kernel probability density of the data across different vitamin types are abbreviated
as: biotin (BIO), cobalamin (COB), folate (FOL), menaquinone (MEN), niacin (NIA), pantothenate (PAN), pyridoxine (PYR), riboflavin (RIB), thiamine
(THI). Suffixes that end with -B are biosynthetic related enzymes. The asterisks on the top indicate ns: p > 0.05, *: p < = 0.05, **: p < = 0.01, ***:
p < = 0.001, ****: p < = 0.0001 (Mann-Whitney Wilcoxon test)
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This provided insights into how a population-specific
microbiome or a microbiome-specific population differs
with respect to vitamin metabolism. Our approach of
computational method enabled us to analyze a targeted
pathway with an identification of the related KEGG
Orthologies. We focused on vitamin metabolism of
human gut microbiota as it might be conserved across
distantly related microbial species, potentially because
they are an integral part of the carbon metabolic network.
Based on the hypotheses and the analyses performed
on fecal metagenomics from four different countries, we
highlight the following findings to assess ecological rela-
tionship between vitamin prototrophs and consumers:
(a) B and K2 vitamin metabolism is prevalent across
most abundant phyla, i.e., Bacteroidetes, Firmicutes,
Actinobacteria, Proteobacteria, Fusobacteria, Verrucomi-
crobia, and Euryarchaeota; (b) Healthy individuals from
China had a significantly higher abundance of these
metabolic genes in comparison to healthy individuals
from Western countries such as Denmark, Spain, and
USA; (c) At metagenomic level, T2D subjects had sig-
nificant changes in the gene abundance profile related to
microbe-mediated vitamin metabolism; whereas only a
part of B-vitamins has been found to differ in their
abundance between healthy controls and IBD subjects;
(d) Dual microbial species (i.e. containing genes for both
biosynthesis and transport of the same vitamin) tend to
co-occur in higher proportion than that with either
traits; (e) Estimation of vitamin-specific pathways from
metabolic reconstructions for abundant microbes reveal
contributions to ecosystem-scale metabolic processes; (f )
Evaluation of their gene expression levels in an IBD co-
hort reveals the significance of microbial contribution
towards the host. Overall, our findings provide valuable
new insights related to vitamin field of metabolism in
the human gut microbiota.
Analogous to the food webs, the equation between
vitamin producers and its consumers cannot be directly
comparable as that of predator-prey relationships for
“public good” (vitamin), as there could be a combination
of factors driving the coexistence of two species to-
gether. Based on the species co-occurrence abundances,
species with dual functional traits were found to be
dominant and with a tendency to cooccur with each
other. This observation is consistent with the notion that
species equipped with diverse set of functional traits
seems to establish resilient communities [21–23]. While
the direction from correlation to causation might not
hold true in every situation, we believe that these
predicted positive and negative associations could imply
reasons other than the parameterized variable. For in-
stance, even though Bacteroides thetaiotamicron could
produce biotin and Bifidobacterium adolescentis could
uptake biotin, we found that B. thetaiotamicron and B.
adolescentis were negatively correlated. As an another
example, Faecalibacterium prausnitzii and Roseburia inu-
linivorans can produce cobalamin, but they were positively
correlated [7, 30]. Experimental in vitro co-culturing of
these pairs (i.e., for their co-growth evaluations) has been
validated by co-occurrence network predictions [30].
Though further study into the micro-ecology of this pat-
tern in a defined gut microbiota model is required, as a
working hypothesis a major driver for co-occurrence
seems to be the ability to cohabitate in a given environ-
ment. This is in agreement with the results of [31] who
found that bacteria evolve and respond according to envir-
onmental changes.
Though the predictions at metagenomics level for the
American cohort revealed no significant difference
between healthy and IBD subjects regarding vitamin-re-
lated gene abundances, it is worth considering to probe
into the expression of biosynthetic enzymes from meta-
transcriptomics. To profile the gut microbiome’s func-
tional capacity about vitamins, we therefore used
metagenomic functional annotation of these genes
encoded in the gut microbiome, and combined this with
available metatranscriptomics data for an IBD cohort.
The gene expression level for vitamin related enzymes
was congruent with previous clinical reports where vita-
min measurements from plasma samples of IBD subjects
reveal a decreased level of cobalamin and thiamine. Al-
though we observed an increase in the expression levels
for biotin in IBD subjects, we also found a pattern where
species with biotin producing potential were abundant
in IBD subjects. These findings suggest that it is not only
the difference in species abundance that sets two groups
apart, it is also the functional features of the abundant
species that contributes to determining a healthy gut
microbiome.
Conclusions
Our study reveals the country-specific differences
between healthy and disease (i.e., T2D and IBD) subjects
for at least some of vitamin biosynthetic pathways,
which highlights the role of diet and lifestyle in the
correlation between human gut microbiota and the
health status of the host. As the diet-derived vitamins
are absorbed in the small intestine, it seems that the
country-specific, microbial genetic content (vitamin
metabolic genes derived from vitamin producing micro-
organisms) in the large intestine accounts for the ob-
served differences in different cases as revealed through
the abundant community-level metabolic reconstruc-
tions. Even if vitamin dysbiosis cannot be associated
with an altered gut microbiota-mediated metabolic
disease, we believe that it may well be an integral part of
the bacterial central carbon metabolism, contributing
among themselves and to the human host. Estimation of
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the contributory levels of human gut microbiota towards
vitamin host absorption, could disentangle the interrela-
tionship between the impact of B-vitamin dosage on gut
microbial members and the host, especially in the gut
microbiota of individuals diagnosed with under- or overnu-
trition and T2D. We are therefore confident that our study
would enable screening for microorganisms with high
potential for vitamin production. In related to screening
results for synthetic communities of vitamin production, it
may become possible to improve the current vitamin
fortification programs in the food-microbiome industries
through the administration of live or attenuated vitamin-
producing bacteria into fermented foods. Such bacteria
may offer a natural alternative than consuming vitamin
fortified foods where their composition are above the
Estimated Average Requirement (EAR) [32].
Methods
Cohort description
Metagenomic sequences subjected to Illumina paired
end sequencing were obtained from European Nucleo-
tide Archive at EMBL-EBI (https://www.ebi.ac.uk/ena)
under the accession number PRJEB2054, PRJNA422434,
PRJNA275349, and PRJNA389280.
From PRJEB2054, 14 and 25 samples were of healthy
controls and IBD subjects from Spain respectively [19].
Healthy controls were recruited among family relatives of
IBD patients; antibiotic treatment for at least 4 weeks be-
fore fecal sample collection was excluded. IBD subjects
were in clinical remission for at least 3months, and had
stable maintenance therapy with mesalazine or azathioprine
[33]. 15 and 70 samples originating from Denmark were of
low-gene count and high-gene count respectively [34].
From PRJNA422434, 187 healthy controls and 172 sub-
jects who were diagnosed with Type 2 Diabetes were ana-
lyzed. These fecal samples were sampled from Shenzhen
Second People’s Hospital, Peking University Shenzhen
Hospital and Medical Research Center of Guangdong
General Hospital, individuals living in the south of China.
Detailed clinical information for the samples is available in
the supplemental information of the original article [13].
From PRJNA389280, 55 healthy controls and 223 IBD
subjects were analyzed. None of the IBD subjects had
history of terminal ileal resection. The samples were
collected and recruited from Massachusetts General
Hospital, Cedars-Sinai Medical Center, and Emory Univer-
sity and Cincinnati Children’s Hospital [35]. Detailed
information on the criteria considered for the sample
inclusion or exclusion on IBD subjects is available in the
original article [14].
Functional mapping and analysis
Vitamin related pathway abundances were calculated
using an open-sourced, stand-alone functional analysis
pipeline FMAP [36]. Metagenomic read sequences were
mapped to the reference database using DIAMOND
[37] as mapping mode. Unique hits that passed through
the default parameters (i.e., e-value >1e-10 and sequence
identity > 80%) of the pipeline FMAP were considered
for further analysis. From the BLAST output files, the
subject sequence identifiers were used for identification
of taxonomic lineage and KO analysis. Gene sequences
as determined by UniRef were mapped to Kyoto
Encyclopedia of Genes and Genomes (KEGG) Ortholo-
gies (KOs) database [38, 39] and were binned into func-
tional categories as listed in Additional file 7: Table
S1-S9. Taxonomic lineage of the mapped hits were
retrieved from the UniProt website (dated on October
2018). For every vitamin type, total normalized abun-
dance, was computed as number of reads that have been
aligned to a gene divided by total number of read counts
in a sample followed by summation of all the genes con-
stituting the pathway. Or in other words, the summation
of the normalized abundances of each vitamin’s KO in
each sample was defined as the total normalized abun-
dance for each vitamin pathway.
Relative abundance of the species was calculated using
MEDUSA [40] for the MetaHIT and T2D cohort. Data
table with relative abundance of species and metatran-
scriptomics data for the HMP2 cohort were obtained
from their publicly available project website [14]. Using
the species abundance values, spearman correlation was
applied to estimate correlations in determining the
relationship between different microbial species. Pairs of
species with correlation coefficient of greater than or
equal to 0.4 were considered as positive correlations.
Pairs of species with correlation coefficient of less than
zero were considered as negative correlation. Based on
the taxonomic information extracted for each of the
mapped protein identifiers from the UniProt, microbial
species encoding proteins required for biosynthesis of a
certain vitamin but lacking transporters for it were
assigned as vitamin prototrophs (producers or ‘P’). The
species having the transporters but lacking the biosyn-
thetic genes for a certain vitamin were assumed as vita-
min auxotrophs (consumers or ‘C’). As well, the species
containing genes for both the biosynthesis and the trans-
port of the vitamin were assigned as dual (producer-con-
sumer or ‘PC’).
For identification of vitamin-dependent enzymes, their
enzyme commission numbers were obtained from
ExPASy (listed in Additional file 7: Table S10).
Metabolic reconstructions
In order to investigate the coverage of vitamin biosynthesis
pathways, previously published repository of human gut
bacterial genome-scale metabolic models were deployed
[41]. These models have a GPR (gene-protein-reaction)
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association component which were used to translate gene
profiles to reactions through logical associations. From this
repository, vitamin biosynthesis profile of the overlapping
species was looked in each cohort. To do so, all the KO
groups related to vitamin biosynthetic reactions as de-
scribed in the previous section were extracted. KEGG reac-
tions were mapped to Kbase [42] nomenclature systems to
be consistent with the reaction identifiers in the metabolic
models. Following identification, a list of biochemical inter-
conversions for each vitamin category, namely, biotin, co-
balamin, folate, niacin, pantothenate, pyridoxine, riboflavin,
thiamine and menaquinone were complied. Subsequently,
the presence and absence of these reactions in each cohort
were analyzed to see how conserved each pathway is across
different populations. Furthermore, for the American and
Chinese cohort, we investigated the presence and absence
of the reactions in biosynthesis pathway of each vitamin
considering the abundance of bacterial species. In each
community, a union list of the present species was con-
structed and sorted according to the relative abundance of
the species in the healthy cohort. Species unique to the
diseased population were then added to the end of the list.
Statistical analyses
All the statistical analysis and graphics were performed
using R version 3.5.1 [43]. Country matched samples
were compared into two groups for differential KO
abundance testing between healthy controls and diseased
subjects to avoid cross country-effects. Statistical analyses
that involved two groups and more than two groups was
performed by Mann-Whitney-Wilcoxon tests and Kruskal
Wallis tests respectively. Bonferroni’s correction was
applied to the significance level. For multivariable linear
regression, categorical metadata and vitamin type abun-
dances, samples were pooled into classifications (male/fe-
male, healthy/diseased, specific nationality/rest, etc) and
significance was identified using Fisher’s exact test with
multiple testing correction of P values.
Additional files
Additional file 1: Table S1. Statistical information on comparison of
vitamin gene abundances between different countries. (XLSX 13 kb)
Additional file 2: Figure S1. Circular plot with links representing the
prevalence of vitamin metabolism among different microbial species
from different phyla of human gut microbiota. (DOCX 374 kb)
Additional file 3: Figure S2. Circular plot with links representing the
prevalence of vitamin metabolism among different microbial species
from different phyla of human gut microbiota. (DOCX 3215 kb)
Additional file 4: Figure S3. Alluvial plot showing the relationship
between the kind of correlation for each vitamin type (biotin, cobalamin
and thiamine) and the possible phenotype combinations. (DOCX 3751 kb)
Additional file 5: Figure S4. Heatmap showing the presence and
absence of reactions associated with gene annotations of vitamin
biosynthetic pathways in genome-scale metabolic models (GEMs) of
abundant gut bacteria. (DOCX 1813 kb)
Additional file 6: Figure S5. Boxplot showing total relative abundance
of species with biotin biosynthesis (BIO-B) and/or biotin transporters (BIO-
T) in samples from American cohort. (DOCX 21 kb)
Additional file 7: Table S1–Table S10. List of all the KEGG Orthologies
(KOs) and Enzyme Commission (EC) numbers that were studied for each
vitamin pathways. (XLSX 31 kb)
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